Lv2
160 积分 2025-03-21 加入
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines
17小时前
已完结
Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies
10天前
已完结
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
21天前
已完结
Advances of IGF-1R inhibitors in Graves’ ophthalmopathy
22天前
已完结
Pharmacodynamics, pharmacokinetics, and toxicology of Fc-growth hormone fusion protein in macaques
1个月前
已完结
Quantitative Pharmacology Methods for Bispecific T Cell Engagers
1个月前
已完结
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
1个月前
已完结
Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
3个月前
已完结
皖公网安备34019202002308
